Esophageal cancer, Esophageal intraepithelial neoplasia,gastric cancer, gastric adenoma, colorectal cancer, colorectal adenoma, Barrett'
Conditions
Interventions
30 cases Period:From August 1 2012 until March 19 2014 DRI or WLI was used alternately in between each bleeding occasion until complete hemostasis was achieved. 3 endpoints were assessed for each b
Sponsors
Center for Research and Development of Minimally Invasive Treatment, Cancer Center, Keio University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patient for esophageal cancer, gastric cancer,gastric adenoma, colorectal cancer,colorectal adenoma, Barrett's esophageal cancer, and subjected to esophageal, gastric and colorectal ESD. 2. Patient that an agreement was obtained.
Exclusion criteria
Exclusion criteria: 1. Patient who judged that we were inappropriate to perform examination safely. 2. Patient that an agreement was not obtained.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.The average time required for hemostasis by hemostatic forceps in DRI is shorter than that in WLI. 2.The easiness of hemostasis is better in DRI than in WLI. 3. The psychological stress for hemostasis in DRI is lower than that in WLI. | — |
Countries
Japan
Contacts
Public ContactNaohisa Yahagi
Keio University Center for Research and Development of Minimally Invasive Treatment, Cancer Center
Outcome results
None listed